Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Priscillia Tosti
Observed name:
P. Tosti
Observed institutions:
Centre National de la Recherche Scientifique,
Université de Montpellier,
Institut de Cancérologie de Lorraine,
Centre de Recherche en Biologie cellulaire de Montpellier,
Université Montpellier 1,
Université de Lorraine
show all 6
OpenAlex ID:
A5020163307
Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
2018
·
Maya Jeitany
, Cédric Leroy
, et al.
·
EMBO Molecular Medicine
·
117
PDF
A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2021
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
·
Clinical Cancer Research
·
50
PDF
Conversational hypnosis versus standard of care to reduce anxiety in patients undergoing marker placement under radiographic control prior to breast cancer surgery: A randomized, multicenter trial
2022
·
Lydie Lemoine
, Virginie Adam
, et al.
·
Frontiers in Psychology
·
8
PDF
Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE)
2018
·
Valérie Bernier-chastagner
, Liza Hettal
, et al.
·
BMC Cancer
·
6
PDF
Abstract 2085: The antileukemic drug nilotinib inhibits the invasive activity and the metastatic potential of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1.
2013
·
Priscillia Tosti
, Cédric Leroy
, et al.
·
Cancer Research
·
1
Supplementary Data I from A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2024
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
Data from A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2024
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
Supplementary Data II from A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2024
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
Supplementary Legend from A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2024
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
Supplementary Table 1 from A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2024
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
Suppl Figure 1 from A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
2024
·
Xavier Sastre-Garau
, Mamadou Diop
, et al.
160P CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
2023
·
M. Betz
, M. Husson
, et al.
·
ESMO Open
PDF
The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1
2016
·
P. Tosti
, C. Leroy
, et al.
·
European Journal of Cancer
Le Nilotinib inhibe les propriétés invasives et métastasantes des cellules de cancer colorectal en ciblant le récepteur à activité tyrosine kinase DDR1
2014
·
Priscillia Tosti
·
theses.fr (ABES)
Abstract 855: The antileukemia drug nilotinib inhibits invasion and metastasis of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1
2012
·
Cédric Leroy
, Priscillia Tosti
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
182
H-index:
4
I10-index:
2
Year
Topic
Type
